Attenuation of renal excretory responses to ANG II during inhibition of superoxide dismutase in anesthetized rats

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 2, 2010, Pages

  Khan, Abdul Hye ^a   Islam, Mohammed Toriqul ^a   Castillo, Alexander ^a   Majid, Dewan Syed Abdul ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Diethyldithiocarbamate; NADPH oxidase; Renal hemodynamics; Sodium excretion; Superoxide dismutase

Indexed keywords

ANGIOTENSIN II; DIETHYLDITHIOCARBAMIC ACID; ENALAPRILAT; LUCIGENIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; LASER DOPPLER FLOWMETRY; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINARY EXCRETION;

EID: 75149158504     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00511.2009     Document Type: Article

References (33)

1. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
2. Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS, Francis J. Chronic NF-κB blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 296: F298-F305, 2009.
3. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239-249, 2002.
4. Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, Dikalov S, Fukai T, Harrison DG. Role of extracellular superoxide dismutase in hypertension. Hypertension 48: 473-481, 2006.
5. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
6. Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol 292: H83-H92, 2007.
7. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, Francis J. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 82: 503-512, 2009.
8. Kober T, König I, Weber M, Kojda G. Diethyldithiocarbamate inhibits the catalytic activity of xanthine oxidase. FEBS Lett 551: 99-103, 2003.
9. Kopkan L, Majid DS. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension 47: 568-572, 2006.
10. Kopkan L, Castillo A, Navar LG, Majid DS. Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 290: F80-F86, 2006.
11. Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Cervenka L, Majid DS. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats. J Hypertens 25: 2257-2265, 2007.
12. Lijnen P, Petrov V, van Pelt J, Fagard R. Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. Am J Hypertens 21: 1129-1136, 2008.
13. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100: 1330-1337, 1999.
14. Maio R, Sepodes B, Figueiredo N, Pinto R, McDonald M, Thiermermann C, Costa P, Mota-Filipe H. Effects of diethyldithiocarbamate (DETC) on liver injury induced by ischemia-reperfusion in rats. Transplant Proc 39: 365-368, 2007.
15. Majid DS, Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
16. Majid DS, Nishiyama A, Jackson KE, Castillo A. Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs. Am J Physiol Renal Physiol 288: F412-F419, 2005.
17. Majid DS, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am J Physiol Regul Integr Comp Physiol 287: R27-R32, 2004.
18. Makino A, Skelton MM, Zou AP, Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25-30, 2003.
19. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 39: 667-672, 2002.
20. Matavelli LC, Kadowitz PJ, Navar LG, Majid DS. Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats. Am J Physiol Renal Physiol 296: F170-F176, 2009.
21. Miller AA, Drummond GR, De Silva TM, Mast AE, Hickey H, Williams JP, Broughton BR, Sobey CG. NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2. Am J Physiol Heart Circ Physiol 296: H220-H225, 2009.
22. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002.
23. Navar LG, Kobori H, Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 5: 135-143, 2003.
24. Omoro SA, Majid DSA, El-Dahr SS, Navar LG. Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs. Am J Physiol Renal Physiol 276: F271-F277, 1999.
25. Qin Z, Reszka KJ, Fukai T, Weintraub NL. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Translational Res 151: 68-78, 2008.
26. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
27. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175: 1181-1194, 1992.
28. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
29. Wei Y, Sowers JR, Clark SE, Li W, Ferrario CM, Stump CS. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase. Am J Physiol Endocrinol Metab 294: E345-E351, 2008.
30. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22-H28, 2005.
31. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, Wilcox CS. Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48: 934-941, 2006.
32. Zhou J, Zhang H, Gu P, Bai J, Margolick JB, Zhang Y. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat 111: 419-427, 2008.
33. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.